NYBCe Names Meghan Delaney CEO to Succeed Hillyer in January 2027
New York – October 12, 2026 -- New York Blood Center Enterprises (NYBCe) has appointed Meghan Delaney, DO, MPH, as President and Chief Executive Officer, effective January 4, 2027, ending Christopher D. Hillyer's 17-year tenure atop the nonprofit blood and life sciences group.
The Board of Trustees selected Delaney following an extensive national search. Hillyer, who has led NYBCe since 2009, will become Special Advisor to the Board of Trustees. He will work with Delaney on the transition and continue to provide strategic guidance to the Board and leadership.